This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy
Nature Communications Open Access 20 October 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frantz, S. Engineered T-cell therapy shows efficacy in blood cancer. Nat Biotechnol 29, 853–854 (2011). https://doi.org/10.1038/nbt1011-853
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1011-853
This article is cited by
-
Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy
Nature Communications (2016)
-
T-Cell Immunotherapy: Looking Forward
Molecular Therapy (2014)
-
Kite and NCI partner on T cells
Nature Biotechnology (2013)
-
CARs in Chronic Lymphocytic Leukemia – Ready to Drive
Current Hematologic Malignancy Reports (2013)
-
Amgen swallows Micromet to BiTE into ALL market
Nature Biotechnology (2012)